Aktis Oncology, Inc.
Aktis Oncology, Inc. (AKTS) Revenue
Annual & quarterly revenue history · segment & region breakdown
AKTS · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsAktis Oncology, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Aktis Oncology, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Aktis Oncology, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Aktis Oncology, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AKTS revenue · 4 questionsAKTS's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Aktis Oncology, Inc. SEC filings · GAAP · Aktis Oncology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026